Pharmacia & Upjohn
Overview[edit]
Pharmacia & Upjohn was a global pharmaceutical company formed through the merger of the Swedish company Pharmacia AB and the American company The Upjohn Company in 1995. The merger combined the strengths of both companies in the pharmaceutical industry, creating a significant player in the global market.
History[edit]
Pharmacia & Upjohn was established in 1995 when Pharmacia AB, a leading pharmaceutical company in Sweden, merged with The Upjohn Company, an American pharmaceutical firm known for its innovative drug development. The merger aimed to leverage the research and development capabilities of both companies to enhance their product offerings and expand their global reach.
Pharmacia AB[edit]
Pharmacia AB was founded in 1911 in Stockholm, Sweden. It was known for its development of biotechnology products and pharmaceuticals, including the production of insulin and other critical medications. Pharmacia AB had a strong presence in Europe and was recognized for its contributions to the field of biotechnology.
The Upjohn Company[edit]
The Upjohn Company was established in 1886 in Kalamazoo, Michigan, USA. It gained a reputation for its innovative approach to drug development and was known for producing a wide range of pharmaceuticals, including antibiotics and hormone therapies. The company was a pioneer in the development of sustained-release medications.
Merger and Operations[edit]
The merger of Pharmacia AB and The Upjohn Company created a new entity with a diverse portfolio of pharmaceutical products. Pharmacia & Upjohn focused on several therapeutic areas, including oncology, endocrinology, and infectious diseases. The company invested heavily in research and development to bring new and innovative drugs to market.
Global Presence[edit]
Pharmacia & Upjohn had a significant global presence, with operations in over 60 countries. The company maintained research facilities and manufacturing plants worldwide, allowing it to serve a diverse customer base and meet the growing demand for pharmaceutical products.
Acquisition by Pfizer[edit]
In 2003, Pharmacia & Upjohn was acquired by Pfizer, one of the largest pharmaceutical companies in the world. The acquisition was part of Pfizer's strategy to expand its product portfolio and strengthen its position in the global pharmaceutical market. Following the acquisition, Pharmacia & Upjohn's operations were integrated into Pfizer's existing business structure.
Legacy[edit]
Pharmacia & Upjohn's legacy continues through its contributions to the pharmaceutical industry, particularly in the areas of biotechnology and innovative drug development. The company's commitment to research and development has had a lasting impact on the availability of effective treatments for various medical conditions.
Related Pages[edit]
Ad. Transform your health with W8MD Weight Loss, Sleep & MedSpa
Tired of being overweight?
Special offer:
Budget GLP-1 weight loss medications
- Semaglutide starting from $29.99/week and up with insurance for visit of $59.99 and up per week self pay.
- Tirzepatide starting from $45.00/week and up (dose dependent) or $69.99/week and up self pay
✔ Same-week appointments, evenings & weekends
Learn more:
- GLP-1 weight loss clinic NYC
- W8MD's NYC medical weight loss
- W8MD Philadelphia GLP-1 shots
- Philadelphia GLP-1 injections
- Affordable GLP-1 shots NYC
|
WikiMD Medical Encyclopedia |
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
